Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

05.10.2026

4 AIDS
1 Antivir Ther
4 HIV Med
2 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
4 J Infect Dis
3 J Virol
1 JAMA
1 Lancet
1 Pediatr Infect Dis J
4 PLoS One
2 PLoS Pathog
3 Proc Natl Acad Sci U S A



    AIDS

  1. FERNANDES GARCIA MV, Lahm T
    HIV-associated pulmonary arterial hypertension: improving survival despite persistent treatment gaps - a systematic review and meta-analysis.
    AIDS. 2026;40:1773-1776.
    >> Share

  2. CLEMENTE T, Capra N, Malagnino V, Lolatto R, et al
    Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.
    AIDS. 2026;40:1769-1773.
    >> Share

  3. KASPROWICZ VO, Deeks SG, Kilembe W, Dong KL, et al
    An inclusive approach for developing global clinical trial recommendations.
    AIDS. 2026;40:1765-1768.
    >> Share

  4. VERA JH
    Cognitive trajectories in HIV: looking beyond the virus to preserve brain health.
    AIDS. 2026;40:1762-1764.
    >> Share


    Antivir Ther

  5. SHEN Y, Huang EY, Yin O, Shiau S, et al
    Kidney function parameters in South African children living with HIV on antiretroviral therapy.
    Antivir Ther. 2026;31:13596535261490958.
    >> Share


    HIV Med

  6. PATHIYIL DV, Wearne N, Price B, Post F, et al
    HIV-associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise.
    HIV Med. 2026 Sep 29. doi: 10.1111/hiv.70315.
    >> Share

  7. FURSA O, Bannister W, Guaraldi G, Kowalska J, et al
    Stability of the HIV cascade of care throughout the COVID-19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016-2022).
    HIV Med. 2026 Sep 29. doi: 10.1111/hiv.70305.
    >> Share

  8. MURATA M, Matsumoto Y, Takayama K, Yamasaki S, et al
    Eight-year changes in hepatic steatosis and associated metabolic factors in a Japanese cohort of people with HIV.
    HIV Med. 2026 Sep 30. doi: 10.1111/hiv.70312.
    >> Share

  9. HEIZMANN E, Farnham A, Grolimund C, Real JF, et al
    Same-night PrEP in community care: The Nightcafe model for male and transgender sex workers.
    HIV Med. 2026 Oct 1. doi: 10.1111/hiv.70313.
    >> Share


    J Acquir Immune Defic Syndr

  10. SHEIRA LA, Mlowe M, Katabaro E, Joseph B, et al
    Missed opportunities for PrEP among the partners of people newly initiated in HIV care in western Tanzania.
    J Acquir Immune Defic Syndr. 2026 Sep 30. doi: 10.1097/QAI.0000000000003968.
    >> Share

  11. BUCCHERI R, Spinelli MA, Saberi P, Neilands TB, et al
    At-Home Point-of-Care Urine Tenofovir Testing for Adherence Monitoring: Feasibility and Comparison with Adherence Metrics in Dried Blood Spots.
    J Acquir Immune Defic Syndr. 2026 Sep 25. doi: 10.1097/QAI.0000000000003953.
    >> Share


    J Am Acad Dermatol

  12. YUN J, Richardson R, Hissaria P, Katelaris C, et al
    Early use of mepolizumab in DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome: A prospective multicenter, open-label, pilot study.
    J Am Acad Dermatol. 2026 Oct 1:S0190-9622(26)03656.
    >> Share


    J Infect Dis

  13. SIM BZ, Steinbrink JM, Miller C, Antonia A, et al
    The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection.
    J Infect Dis. 2026 Oct 1:jiag497. doi: 10.1093.
    >> Share

  14. ALKHAFAJI S, Yang E, Lee K, Chang VK, et al
    Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis.
    J Infect Dis. 2026 Sep 30:jiag431. doi: 10.1093.
    >> Share

  15. HODGSON SH, McCarthy JS, Duncan JA, Williams E, et al
    Expert Consensus on Controlled Human Infection Studies for Gonorrhoea.
    J Infect Dis. 2026 Sep 26:jiag486. doi: 10.1093.
    >> Share

  16. POLISENO A, Rahangdale L, Schauer A, Sykes C, et al
    Changes in Doravirine Pharmacokinetics During Pregnancy: A Longitudinal Single Dose Study.
    J Infect Dis. 2026 Sep 26:jiag484. doi: 10.1093.
    >> Share


    J Virol

  17. ZENG M, Liu D, Zhang J, Zhang L, et al
    MOV10 inhibits SADS-CoV replication by enhancing TRIM24-mediated K63-linked TRAF3 ubiquitination, and this inhibition is antagonized by viral N protein.
    J Virol. 2026 Sep 29:e0121526. doi: 10.1128/jvi.01215.
    >> Share

  18. SONG Y, Xia T, Martin C, Despres G, et al
    Functional redundancy, complementation, and cross-talk between CH25h and IFITM3 in infection and in IFITM3 trafficking and secretion.
    J Virol. 2026 Sep 28:e0137826. doi: 10.1128/jvi.01378.
    >> Share

  19. YUAN J, Yang W, Xu M, Hu H, et al
    Deubiquitinase USP8 inhibits HIV-1 replication by suppressing Tat-mediated viral transactivation.
    J Virol. 2026 Sep 28:e0059826. doi: 10.1128/jvi.00598.
    >> Share


    JAMA

  20. DE AVILA L, AlNaamani KM, Papatheodoridi M, Petta S, et al
    Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.
    JAMA. 2026 Sep 30:e2618491. doi: 10.1001/jama.2026.18491.
    >> Share


    Lancet

  21. BRINK N, Butler R, Machingura F, Chersich M, et al
    Declare the climate crisis a Public Health Emergency of International Concern.
    Lancet. 2026 Sep 29:S0140-6736(26)01919-7. doi: 10.1016/S0140-6736(26)01919.
    >> Share


    Pediatr Infect Dis J

  22. TORRES-FERNANDEZ D, Fernandez-Luis S, Dominguez-Rodriguez S, Nhampossa T, et al
    HIV-1 Drug Resistance in Mother-Infant Pairs in Southern Mozambique.
    Pediatr Infect Dis J. 2026 Sep 28. doi: 10.1097/INF.0000000000005426.
    >> Share


    PLoS One

  23. MONFORT SANCHEZ E, Watson AF, Haider T, Chrysostomou D, et al
    Assessment of epithelial barrier integrity in cellular monolayer models using low cost, clinically approved fluorescent contrast agents.
    PLoS One. 2026;21:e0358746.
    >> Share

  24. NYUKURI D, Abongo M, Mbithi A, Kundu C, et al
    "The injection gives freedom" - An exploration of long-acting injectable HIV treatment acceptance among patients seeking care in two Nairobi tertiary hospitals.
    PLoS One. 2026;21:e0320713.
    >> Share

  25. RICO-BOLIVAR DL, Diaz-Brochero C, Hattemer R, Bejarano-Mora CA, et al
    Causes of hospitalization among people living with HIV in a tertiary-care hospital in Bogota, Colombia, 2018-2024.
    PLoS One. 2026;21:e0357788.
    >> Share

  26. LIANG Y, Wang M, Zhang Y, Mo J, et al
    Exploring the relationship between HIV Testing frequency and sexual behavior, prevention prophylaxis use among MSM in Southern China.
    PLoS One. 2026;21:e0358578.
    >> Share


    PLoS Pathog

  27. WANG D, Ding W, Xu J, Li R, et al
    Structural basis of diverse substrate recruitment by the HIV-1 Vpr-hijacked CRL4(VprBP) E3 ligase.
    PLoS Pathog. 2026;22:e1014610.
    >> Share

  28. VISWANATHAN P, Bersonda JR, Gill J, Navarro A, et al
    The Mitochondrial ubiquitin ligase MARCHF5 cooperates with MCL1 to inhibit Apoptosis in KSHV-transformed primary effusion lymphoma cell lines.
    PLoS Pathog. 2026;22:e1014665.
    >> Share


    Proc Natl Acad Sci U S A

  29. HE ST, Zheng Y, Ying R, Xu X, et al
    Zinc mediates the allosteric activation of Shiftless to suppress programmed -1 ribosomal frameshifting.
    Proc Natl Acad Sci U S A. 2026;123:e2608087123.
    >> Share

  30. HOGARTY MP, Li H, Zhao C, Martella CL, et al
    Deletions in variable region 1 of the HIV envelope accelerate V3-glycan bNAb induction in SHIV-infected rhesus macaques.
    Proc Natl Acad Sci U S A. 2026;123:e2620354123.
    >> Share

  31. YU L, Ajiro M, Majerciak V, Lobanov A, et al
    SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERalpha and FOXA.
    Proc Natl Acad Sci U S A. 2026;123:e2536317123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016